- 영문명
- Effect of Bevacizumab on Survival and Production of Nitric Oxide in Trabecular Meshwork Cells
- 발행기관
- 대한안과학회
- 저자명
- 김신후 김재우,Sin Hoo Kim, MD, Jae Woo Kim, MD, PhD
- 간행물 정보
- 『대한안과학회지』Ophthalmological Society,volume50,number9, 1404~1408쪽, 전체 5쪽
- 주제분류
- 인문학 > 역사학
- 파일형태
- 발행일자
- 2009.09.15

국문 초록
영문 초록
Purpose: To investigate the effect of bevacizumab, a monoclonal antibody against vascular endothelial growth factor (VEGF), on the survival and production of nitric oxide (NO) in human trabecular meshwork cells (HTMC). Methods: Primarily cultured HTMC were exposed to 0, 0.25, 1.0, and 2.5 mg/ml bevacizumab for 24 hours. Cellular survival and production of NO were assessed by MTT assay and Griess assay, respectively. Results: Bevacizumab did not affect the cellular survival at low concentrations but decreased cellular survival significantly at high concentrations (>1.0 mg/ml) accompanied with increased NO production. Conclusions: High concentrations of bevacizumab may be toxic to HTMC.
목차
해당간행물 수록 논문
참고문헌
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!
